ask="N/A"
ask_size="N/A"
average_daily_volume="1149860"
bid="45.50"
bid_size="100"
book_value="10.71"
change="-1.42"
change_from_200_day_moving_average="-4.03"
change_from_50_day_moving_average="5.18"
change_from_52_week_high="-33.25"
change_From_52_week_low="15.48"
change_in_percent="-2.94%"
close="46.86"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.09"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.74"
ex_dividend_date="N/A"
float_shares="71056000"
high="48.59"
high_52_weeks="80.11"
last_trade_date="2/21/2017"
last_trade_price="46.86"
last_trade_size="76724"
last_trade_time="4:00pm"
low="46.37"
low_52_weeks="31.38"
market_capitalization="4.03B"
moving_average_200_day="50.89"
moving_average_50_day="41.68"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="48.59"
pe_ratio="N/A"
peg_ratio="-0.21"
percent_change_from_200_day_moving_average="-7.92%"
percent_change_from_50_day_moving_average="+12.43%"
percent_change_from_52_week_high="-41.51%"
percent_change_from_52_week_low="+49.33%"
previous_close="48.28"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.51"
price_per_sales="88.06"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="728226"
weeks_range_52="31.38 - 80.11"
